Understanding strategic decision-making in pharma from molecule to market
Training the enterprise mindset across the pharma value chain.
As roles in pharma become increasingly specialised, employees can risk losing sight of how their work fits into the broader value chain. This course, created in collaboration with Atrium, helps participants develop an enterprise mindset by understanding how decisions from early discovery to market launch influence the entire journey of a medicine.
The course is highly interactive and practice‑oriented. Together, we explore business‑critical decisions across R&D, clinical development, manufacturing, market access, and commercial functions. Participants gain insight into how HQ and affiliates can collaborate more effectively and how cross‑functional contributors can create value beyond their own silo.
Key themes
- Enterprise mindset
- Pharmaceutical value chain
- From molecule to market
- Business-critical decision-making
What you will learn
- An introduction to the full pharmaceutical value chain and its strategic decision points.
-
How global headquarters and local affiliates collaborate across markets.
-
How development and clinical trial decisions shape commercial work with healthcare systems.
- Considerations around scalability, formulations, and administration of a potential drug.
- What drives commercial, including differentiation and payer priorities.
- Perspectives on manufacturing, supply planning, and meeting market demands
What your company gains
- Employees with a stronger understanding of the big picture.
- Improved their cross-functional collaboration and smoother handovers.
- Greater empathy and understanding with both HQ and affiliate perspectives.
- Leadership insights into communicating strategy and anticipating resistance.
Who should attend
- New to the pharmaceutical industry (up to 2 years) or if you move from one specialist role to another or into a leadership role
Overall details
Registration deadline: 7 April 2026
Course price: 10,000 DKK
